Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates; Continues Development of Two Investigational Therapeutic Candidates

Created on 2021-01-26T13:00:44-06:00

Return to the Index

This card pertains to a resource available on the internet.

This card can also be read via Gemini.

Merck cancels vaccine. Prefers to sell treatments taken every day for some days until treated.